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Neural tube defects including anencephaly, encephalocele, and spina bifida 
are major congenital malformations with multifactorial etiology, and with a 
great variation in their prevalence in different populations. The study on the 
prevalence of these malformations may be helpful in planning strategies for their 
prevention. The aim of this epidemiologic descriptive study was to determine 
the prevalence of neural tube defects and to describe their birth characteristics 
in Motahhari hospital, Urmia, West Azerbaijan.
Materials and Methods
A cross-section observational study was carried on the hospital-based charts of 
consecutive 13997 live-births and 124 stillbirths during the period January 2001 
through June 2005. The defects categorized based on the domains of anencephaly, 
spina bifida, and encephalocele according to standard definitions.  
Results
During this period, 117 cases were detected with neural tube defects, giving 
an overall prevalence of 8.29/1000. Of 117 cases, 81 (69.23%) cases were seen 
among stillbirths and 36 (30.77%) cases among live-births, that is, the prevalence 
of neural tube defects for stillbirths and live-births were 653.2/1000 and 2.57/1000 
respectively. The yearly prevalence varies between 6.99/1000 and 9.82/1000 over 
the 4.5-year period. The major lesion was anencephaly with prevalence of 
5.52/1000 (66.67% of all neural tube defects). Approximately, two-thirds (66.09%) 
of cases were found in females. Weights of 73.36% of anencephalic cases were 
less than 1000 grams.
Conclusion
In this study, the prevalence of neural tube defects is among the highest reported 
rates. There was a significance difference in the prevalence of anencephaly, as 
the most prevalent NTD, between live-births and stillbirths. These findings may 
necessitate an intensive approach to periconceptional folic acid supplementation 
as a possible strategy to reduce the prevalence of these defects.




Neural tube defects (NTDs) are major congenital defects with multifactorial etiology 
and the genes that are involved in the metabolism of folate and homocysteine are 
reported to play a role in the development of NTDs (1,2). Anencephaly, spina bifida, 
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and encephalocele are the most common diagnoses 
used to describe these birth defects. They arise when 
the neural tube fails properly to develop into the brain 
and spinal cord during the first month of pregnancy. 
There is a great variation in the prevalence of NTDs in 
different populations (3-7). In a multi-centric study in 
20 regions of Europe, the total prevalence rates have 
been between 1.15/1000 and 3.8/1000 during 1980-1986 
(8). Prevalence of 0.78/1000 births has been reported 
in the Asir region of Saudi Arabia (6). The total NTDs 
prevalence in Ontario, Canada between the years 1986 
and 1999 has been varied from 0.86 per 1000 to 1.62 per 
1000 live-births stillbirths, and therapeutic abortions (9). 
Incidence of NTDs in the least-developed area of India 
has been shown to be 6.57-8.21 per 1000 live-births (7). 
According to a hospital-based study, the prevalence of 
NTDs was 5.49/1000 among Palestinians (10).
The aim of the current study was to find the prevalence 
of NTDs and to describe their birth characteristics in a 
referral hospital of Urmia. Since NTDs often result in fetal 
death, early-life death, and developmental disabilities 
among surviving infants and children, prevention 
could be an important strategy to relief NTDs burden. 
Determination of NTDs prevalence in a population 
may help adopting prevention strategies such as well-
documented periconceptional folic acid supplementation 
which has been reported to have prevention effects on 
NTDs (11-13).
Materials and Methods
We designed a cross-section observational study to 
survey medical records of births and stillbirths for a 4.5-
year period, from January 2001 to June 2005. It carried 
out at Motahhari hospital which is a referral obstetrics 
hospital in the west Azerbaijan province with 2.9 million 
populations. Data were collected from documented 
hospital-based records of 13997 live-births, and 124 
stillbirths.
In this study, the domains of anencephaly, spina bifida, 
and encephalocele were considered according to standard 
definitions. This domain for anencephaly included 
craniorachischisis, iniencephaly, and other neural tube 
defects (encephalocele and spina bifida) when associated 
with anencephaly. Accordingly, the domain of spina 
bifida included meningocele, meningomyelocele, and 
rachischisis. Spina bifida was not counted as a separate 
defect when present with anencephaly. The definition 
also excluded spina bifida occulta and sacrococcygeal 
teratoma without dysraphism. Encephalocele was not 
counted as a separate defect when present with spina 
bifida.
We calculated the total number and prevalence of NTDs 
by combining the numbers of NTDs occurring in live 
births, and stillbirths. We examined overall secular trends 
using poisson regression analysis for the number of 
NTDs diagnosed per year (2001-2005), considering the 
year as a continuous independent predictor variable. The 
Chi square test for homogeneity in proportions was used 
to test whether differences in total prevalence rates were 
significant between sexes or weight groups of cases. 
Results
A total of 117 infants and fetuses with neural tube defects 
were detected among all live births, and stillbirths, that 
is, 14121 cases (table 1). This gives a prevalence of 8.29/
1000.
The most common defect was anencephaly with78 
cases (66.67%) followed by spina bifida with 35 cases 
(29.91%) and encephalocele with 4 cases (3.42%). The 
yearly prevalence varies between 6.99/1000 and 9.82/
1000 over the 4.5-year period. The yearly prevalence 
difference was not significant (p=0.07).
Considering the sex of cases, 76 cases were female, 
39 cases were male, and the sex of 2 cases was 
undetermined. Excluding the cases with un-known sex 
from calculation, totally 66.09% of cases were female. 
The sex difference in NTDs prevalence was significant 
(p=0.003). Totally 81 out of 117 (69.23%) cases were 
delivered stillborn, and regarding the type of NTDs this 
figure for anencephaly, spina bifida, and encephalocele 
was 93.59%, 17.14%, and 50% respectively.
To find any association between the prevalence of NTDs 
and the fetus and neonate weight, their weights have been 
grouped into three groups (table 3). With increasing fetal 
and neonatal weights, the NTDs prevalence decreases 
(p=0.00). Table 4 shows the relation between maternal 
age and the prevalence of neural tube defects.
Discussion
The prevalence of all types of NTDs varies greatly in 
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different parts of the world, ranging from 0.78/100 to 
8.21/1000 (6-10). According to our study, the overall 
prevalence of NTDs is 8.29 per 1000, which in 
comparison with the reported rates, is among the highest. 
The incidence of NTDs reported in India (7) i.e., 6.57-
8.21/1000 live-birth is higher than that in our study, that 
is 2.57/1000 live-birth.
Descending order of NTDs rates was for anencephaly 
(66.67%), spina bifida (29.91%), and encephalocele 
(3.42%). This order compatible with findings of a 
population-based study in California with rates of 
49%, 42%, and 8% for anencephaly, spina bifida, and 
encephalocele respectively (14).
Females are more likely than males to have anencephaly 
and spina bifida. In a case-control study, about 70 percent 
of the children with anencephaly and 60 percent of the 
children with spina bifida were female (15). Our finding 
is compatible with this finding, that is 69.74% of cases 
with anencephaly and 60% of cases with spina bifida 
were females.
In this study, there is a higher rate of neural tube defects 
among children delivered with low birth weights. Among 
all infants born with neural tube defects 54.71% of cases 
had weight under 1000 grams, and 75.23% were low 
birth weight (less than 2500g) (table 3). This suggests 
that lethal neural tube defects are a likely cause of early 
fetal loss.
Approximately 74.36% of anencephalic cases weighed 
less than 1000g (table 3). 69.23% of NTDs had been seen 
in stillbirths, this figure was 83% in a study in England, 
and Wales (16). Only 6.41% had birth weights of 2,500g 
or more. Among infants with spina bifida, 14.29% were 
less than 1000g, and 65.71% weighed 2500 g or more. 
There is also an association between maternal age and the 
prevalence of neural tube defects so that the prevalence 
of NTD-affected pregnancies decreased with increasing 
maternal age (17,18). 
Although we found that 57.27% of NTDs occur in groups 
with maternal age 20-29, due to lack of information 
about the maternal age of 14004 unaffected cases, we 
can not interpret these findings. Another limitation of 
study is that we did not find registered information about 
the location of spina bifida lesions in the charts. And 
also, due to carrying out the study in a referral hospital, 
data can't be extended to the overall prevalence of the 
NTDs in the region. 
Table 1: Number of NTDs regarding the year of occurrence from 2001-2005; in the year 2005, cases in the first 
half of the year included.
Year Anencephaly Spina Bifida Encephalocele
Total number of 
NTDS
2001 22 7 0 29
2002 22 8 3 33
2003 15 6 0 21
2004 12 9 1 22
2005 7 5 0 12
total 78 35 4 117
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 Table 2: Yearly prevalence of NTDs from 2001 to 2005; in the year 2005, cases in the first half of the year 
included.
Year total number of NTDs total number of births 
yearly prevalence per 1000 
birth 
2001 29 3268 8.87
2002 33 3360 9.82
2003 21 3005 6.99
2004 22 2944 7.47
2005 12 1544 7.77











No. % No. % No. % No. %
<1000 58 74.36 5 14.28 1 25 64 54.71
1000-
2500 15 19.24 7 20 2 50 24 20.52
>2500 5 6.4 23 65.71 1 25 29 24.78











No. % No. % No. % No. %
<20 11 14.10 3 8.57 1 25 15 12.82
20-24 25 32.05 8 22.86 1 25 34 29.06
25-29 21 26.92 10 28.57 2 50 33 28.21
30-34 9 11.54 6 17.14 0 0 15 12.82
≥35 12 15.38 8 22.86 0 0 20 17.09
NEURAL TUBE DEFECTS PREVALENCE IN A HOSPITAL-BASED STUDY IN URMIA
23Iran J Child Neurology  June  2008
Reference
1.       Shurtleff DB, Lemire RJ. Epidemiology, etiologic factors, 
and prenatal diagnosis of open spinal dysraphism. 
Neurosurg Clin N Am 1995; 6:183-193.
2.      Gos M, and Szpecht-Potocka A. Genetic basis of neural 
tube defects. II. Genes correlated with folate and 
methionine metabolism. J Appl Genet 2002; 43(4): 511-
524.
3.       Verma I. High frequency of neural-tube defects in North 
India.Lancet 1978; 1: 879–80.
4. Kulkarni ML, Mathew MA, Ramchandran S. High 
incidence of neural tube defects in South India. Lancet 
1987;1:1260.
5.        Xiao KZ, Zhang ZY, Su YM, et al. Central nervous system 
congenital malformations, especially neural tube defects in 
29 provinces, metropolitan cities and autonomous regions 
of China: Chinese Birth Defects Monitoring Program. Int 
J Epidemiol  1990; 19: 978–82.
6.       Asindi A and Al-Shehri A. Neural tube defects in the asir 
region of saudi arabia Ann Saudi Med 2001; 21(1-2):26-
29. 
7.      Cherian A, Seena S, Bullock RK, Antony AC. Incidence 
of neural tube defects in the least-developed area of India: 
a population-based study. Lancet  2005; 366: 930–31.
8.     EUROCAT Working Group. Prevalence of neural tube 
defects in 20 regions of Europe and the impact of prenatal 
diagnosis, 1980-1986. Journal of Epidemiology and 
Community Health  1991; 45:52-58.
9.      Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. 
Incidence of neural tube defects in Ontario, 1986-1999. 
CMAJ 2001;167(3):237-240.
10.  Dudin A. Neural tube defect among Palestinians: a 
hospital-based study. Ann Trop Paediatr  1997; 17 (3): 
217-222.
11. Grosse SD, Collins JS. Folic acid supplementation and 
neural tube defect recurrence prevention. Birth Defects 
Res A Clin Mol Teratol  2007; 79 (11): 737-742.
12.   Mills JL, Signore C. Neural tube defect rates before and 
after food fortification with folic acid. Birth Defects Res 
A Clin Mol Teratol  2004;70(11): 844-845.
13. Wani MA. Neural tube defect and folic acid. JK Pract 
2000;7(1): 13 
14.    Feuchtbaum LB, Currier RJ, Riggle S, Roberson M, Lorey 
FW, Cunningham GC. Neural tube defect prevalence 
in California (1990-1994): eliciting patterns by type of 
defect and maternal race/ethnicity. Genet Test 1999; 3 (3): 
265-272. 
15.   Whiteman D, Murphy M, Hey K, O’Donnell M, Goldacre 
M. Reproductive factors, subfertility and risk of neural 
tube defects: a case-control study based on the Oxford 
Record Linkage Study Register. American Journal of 
Epidemiology  2000;152(9): 823-828.
16.   Morris JK, Wald NJ. Prevalence of neural tube defect 
pregnancies in England and Wales from 1964 to 2004. J 
Med Screen  2007;14(2): 55-59.
17.    McDonnell RJ, Johnson Z, Delaney V, Dack P. East 
Ireland 1980-1994: Epidemiology of Neural Tube 
Defects. Journal of Epidemiology and Community Health 
1999;53(12): 782-788.
18.   Owen TJ, Halliday JL, Stone CA. Neural Tube Defects 
in Victoria, Australia: Potential Contributing Factors and 
Public Health Implications. Australian & New Zealand 
Journal of Public Health 2001;24(6):584-589.
NEURAL TUBE DEFECTS PREVALENCE IN A HOSPITAL-BASED STUDY IN URMIA
